MyEG to be made distributor of Zhifei vaccine


MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

PETALING JAYA: My E.G. Services Bhd has entered into a memorandum of understanding (MoU) with Anhui Zhifei Longcom Biopharmaceutical Co Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MyEG Services , distributor , Zgifei , vaccine ,

Next In Business News

Japan's interest rate normalisation seen to have greater impact on Asia than Europe
IEA sees gradual Hormuz recovery tipping into significant 2027 surplus
Oil extends fall, stocks steady as traders wait on Warsh
China makes new push to take yuan global, vows vigilance against financial risks
Oil slides on Iran supply prospects as traders wait on Warsh
ESG-ready Malaysian businesses better positioned to penetrate EU market, says GRI
Airbus confirms cancellation of AirAsia X order for 15 A330-900 aircraft
Dollar on the defensive ahead of first Fed decision under Warsh
Singapore's May exports rise bigger-than-expected 38.4% y-o-y, boosted by AI demand
Japan's exports beat forecast in May on strong chip demand

Others Also Read